Home
HomeChat
Markets
AlertsCalendarScreenerCharts
Portfolio
WatchlistsPortfolioFiles
Account
Docs
Sign upJoinLog inLogin

Olema Pharmaceuticals, Inc. (OLMA) stock profile

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

Key facts

SymbolOLMA
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CEOSean Bohen
Employees96
HeadquartersSan Francisco, CA, US
IPO2020-11-19
Websitewww.olema.com

Explore OLMA on Vantafin

  • Olema Pharmaceuticals, Inc. Overview
  • Olema Pharmaceuticals, Inc. Financials
  • Olema Pharmaceuticals, Inc. News
  • Olema Pharmaceuticals, Inc. Events
  • Olema Pharmaceuticals, Inc. SEC filings
  • Olema Pharmaceuticals, Inc. Insider transactions

Frequently asked questions

What does Olema Pharmaceuticals, Inc. (OLMA) do?
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
Where is OLMA stock listed?
Olema Pharmaceuticals, Inc. trades under the ticker OLMA on NASDAQ.
How can I research OLMA's financials and filings?
Vantafin provides Olema Pharmaceuticals, Inc.'s income statement, balance sheet and cash-flow data, SEC filings, earnings-call transcripts, and insider & institutional ownership on the OLMA profile.